Navigation Links
Reportlinker Adds Global Angiongenesis Inhibitors and Stimulators Industry
Date:3/21/2011

FDA's Subpart H Approval for Revlimid in

Myelodysplastic Syndromes 72

US FDA Approves OSI's Tarceva® for Treating Pancreatic Carcinoma 72

OSI Obtains FDA Approval for Tarceva™ In the Treatment of NSCLC 73

FDA Grants Approval to Erbitux® in the Treatment of Metastatic

Colorectal Carcinoma 73

AstraZeneca Obtains FDA Approval for Iressa in NSCLC Treatment 74

9. RECENT INDUSTRY ACTIVITY 75

Genentech to Carry Out Additional Trial of Avastin in Her2-

negative mBC 75

Pfizer to Seek regulatory Clearance for Axitinib in Europe and US 75

FDA to Withdraw Avastin's Approval for Breast Cancer 75

Eyetech Receives QTDP Grant To Develop Extended- Release

Formulation of Macugen® 75

sanofi-aventis and Regeneron to Continue VELOUR Trial as Planned 76

EntreMed Enters into Financing Deal for ENMD-2076 Development 76

Chugai Pharmaceuticals Fulfills Condition for Avastin's Approval 76

Gilead Sciences to Take Over CGI Pharma 77

Mersana Commences XMT-1107 Phase I Clinical Trial 77

Astellas Pharma Acquires OSI Pharmaceuticals 77

Roche to Conduct a Trial on Anti-Cancer Antibody TB-403 77

Mersana Therapeutics Inks License Agreement With Teva 78

Acceleron Publishes Pre-clinical Data Study on ACE-041 78

Antisense Raises Capital to Continue Phase III Trabedersen Trial 78

GSK Receives Positive Opinions from EMEA for Two Cancer Medicines 79

EMEA Issues Positive Opinion on GSK's Votrient 79

EMEA Issues Positive Opinion on GSK's Anti Cancer Drug

Candidate, Tyverb 79

Abbott Enters into Licensing Agreement with Pierre Fabre 80

Arno Therapeutics Inks Global Licensing Agreement with OSU 80

BI Initiates Late Stage Clinical Trials for Two Oncology Drug

Candidates 80

AnGes Obtains US FDA Approval for Phase III Trial of Collategene™ 80

Silence Therapeuti
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... July 27, 2015 IDEXX Laboratories, Inc. (NASDAQ: ... clinics have submitted over 100,000 specimens to IDEXX Reference ... the first 10 days since the breakthrough kidney function ... is a leading cause of suffering and death in ... are consistent with generally accepted kidney disease prevalence data ...
(Date:7/26/2015)... ... July 26, 2015 , ... ... ANEMIA calibration verification / linearity test kit. The VALIDATE® ANEMIA kit contains Ferritin, ... kit is prepared using the CLSI recommended “equal delta” method for linearity testing ...
(Date:7/24/2015)... 2015 Ryan & Maniskas, LLP that ... District Court for the Northern District of California ... purchased the common stock of Avalanche Biotechnologies, Inc. ("Avalanche" or ... and June 15, 2015, inclusive (the "Class Period"). ... the Court for appointment as a lead plaintiff of the ...
(Date:7/24/2015)... NEW YORK , July 24, 2015 ... the following equities: PDL BioPharma Inc. (NASDAQ: PDLI ... Inc. (NASDAQ: STEM ), Northwest Biotherapeutics Inc. (NASDAQ: ... ACOR ). Free research report on PDL BioPharma can ... 23, 2015, the NASDAQ Composite ended at 5,146.41, down ...
Breaking Biology Technology:Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 4Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 5Maine Standards Company, LLC Announces Release of VALIDATE® ANEMIA Calibration Verification / Linearity Test Kit 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 2Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Avalanche Biotechnologies, Inc. 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5
... SPRINGFIELD, N.J., July 9 Adding to the ... reimbursement,actions are in motion by the American Medical ... proponents to eliminate commercial,support of certified CME. Certified ... new information is communicated to physicians so that ...
... ANN ARBOR, Mich., July 9 Terumo Cardiovascular ... patent infringement complaint in,Germany against two affiliates of ... Maquet Vertriebs und Service Deutschland GmbH. The complaint,alleges ... 7,Endoscopic Vessel Harvesting Systems, infringe a patent for ...
... after recent CE clearance Ovalum Ltd., a privately ... the launch of sales of its new CiTop™ ... vasculature. The devices are intended to assist ... (CTO). These obstructions are hard to traverse and ...
Cached Biology Technology:Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates 2Ovalum Ltd. Announces Sales Launch of CiTop™ Product-Line in Europe 2
(Date:7/21/2015)... , July 21, 2015 Passwords have ... seen in the recent U.S. Office of Personnel ... to the infosec conundrum, but developers and end-users ... To address this dilemma, Biometrics-as-a-Service provider HYPR Corp. ... Tokenization SDK for third party integration. ...
(Date:7/13/2015)... Calif. , July 13, 2015 ... developer of human interface solutions, today announced sampling ... touch and display driver integration (TDDI) product targeting ... the first to combine Synaptics , best-in-class ... proven display driver technology developed in the company,s ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, 2015 /PRNewswire/ ... human interface solutions, announced today that it will report ... 2015 on Thursday, July 30, 2015 after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... (VBI) at Virginia Tech have constructed a mathematical and ... to simulate the cellular and molecular changes underlying chronic ... to explore different interactions of cells in the immune ... in the colon, and identify intervention points to perhaps ...
... University of British Columbia zoologist has discovered a new ... and one of the earliest vertebrates dating back 500 ... evolution of steroid hormones and may help conservation and ... significant scientific implications and application for lamprey conservation," says ...
... WOODS HOLE, MAWhen searching for long-lost treasure, sometimes all ... "flashlight," developed at the Marine Biological Laboratory,s (MBL) Josephine ... long-neglected cellular component the nucleolinus and confirm ... and Mary Anne Alliegro, and MBL visiting investigator Jonathan ...
Cached Biology News:Math model of colon inflammation singles out dangerous immune cells 2Math model of colon inflammation singles out dangerous immune cells 3UBC researcher discovers ancient 'stress hormone' in pre-historic fish 2Rediscovery: MBL scientists confirm role for mysterious cell component, the nucleolinus 2
... ANTI-RNase is a protein ribonuclease inhibitor that noncovalently ... No inhibition is seen with RNase 1, T1, ... distinct from human placental ribonuclease inhibitor in that ... and does not release active RNase in the ...
... Ribonuclease Inhibitor is a recombinant protein that ... of RNA in the preparation of cDNA by ... in vitro protein synthesis. RNA Safe Inhibitor tightly ... a broad range of eukaryotic RNases such as ...
... Natural and Recombinant RNasin Ribonuclease Inhibitors ... the inhibition of eukaryotic RNases of the ... its inhibitory effect by noncovalently binding to ... value for the binding of RNasin Ribonuclease ...
...
Biology Products: